OR WAIT null SECS
James Song, MD
Director of Clinical Research
Frontier Dermatology
Mills Creek, WA
September 18, 2025
Video
This interview segment highlights Song’s risankizumab data covered during the 2025 EADV Congress in Paris.
September 17, 2025
Eingun James Song, MD, highlights recent phase 4 data on risankizumab for patients with moderate to severe scalp and genital psoriasis.
July 24, 2025
This interview segment highlights additional information on the 16-week risankizumab data from the phase 4 UnlIMMited study.
This interview with Song at DERM2025 highlights recent phase 3 data on risankizumab for genital and scalp psoriasis.